Protein Characterization and Identification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
The hospital sector in Turkey is experiencing significant growth and modernization, with the country making substantial investments in healthcare infrastructure. This has resulted in the construction of new hospitals and the expansion and renovation of existing ones. The Turkey Hospital Market is expected to grow at a significant rate during the forecast period of 2024-2028, driven by increasing medical tourism and the rise in healthcare needs. The hospital market is dominated by the general hospital segment, and Turkey has both public and private hospitals, with the public sector dominating the healthcare industry. The Ministry of Health oversees the public healthcare system and operates many hospitals across the country. Private hospitals are growing in popularity, particularly in major cities like Istanbul, Ankara, and Izmir.
The growth of Turkey's hospital industry is influenced by factors such as a rising population, escalating healthcare requirements, and the emergence of medical tourism. Turkey has emerged as a favored choice for medical tourists seeking healthcare that is both excellent and cost-effective. This trend has spurred the establishment of specialized hospitals, notably focusing on areas like plastic surgery, dentistry, and ophthalmology.
On the whole, Turkey's hospital sector is predicted to maintain its upward trajectory, propelled by an increasing demand for healthcare services and investments in healthcare infrastructure. Nevertheless, challenges such as escalating healthcare expenses and a scarcity of medical professionals might impede sustained expansion within the sector.
Government Investments in Healthcare Infrastructure Drive the Turkey Hospital Market
Government investments have played a pivotal role in propelling Turkey's hospital industry forward. In recent years, the Turkish government has committed substantial resources to enhance healthcare infrastructure, encompassing the establishment of novel hospitals and the rejuvenation of existing ones. These investments have contributed to a noticeable expansion in the array of hospitals and healthcare facilities accessible to the general public.
The government has initiated several strategies to enhance healthcare accessibility, particularly in remote regions. As of 2021, the Turkish government executed a scheme aimed at bolstering healthcare access by constructing additional hospitals. This endeavor was a component of a broader undertaking that commenced in 2003 to enhance the nation's healthcare system. The exigencies of the COVID-19 pandemic underscored the necessity to ameliorate healthcare access within Turkey. In response, the government has been diligently working to revolutionize the healthcare sector to ensure that all citizens can avail themselves of high-quality services.
Furthermore, the Turkish government has been actively endorsing public-private partnerships (PPPs) within the healthcare sphere, with the aim of augmenting healthcare service quality and operational efficiency. These partnerships involve the collaboration of the private sector in financing, constructing, and operating healthcare facilities in conjunction with governmental entities.
Collectively, these initiatives have been instrumental in fostering the expansion of Turkey's hospital market, bolstering the availability and caliber of healthcare services. As the Turkish population experiences continued growth and aging, the demand for healthcare services is anticipated to intensify, thereby catalyzing sustained government investments in healthcare infrastructure and the ongoing progression of the hospital market.
Private Sector Investment Boost the Market Expansion
The substantial growth of Turkey's hospital market has been significantly propelled by investments from the private sector. Increasingly, the private sector has been channeling investments into Turkey's healthcare landscape, particularly within prominent urban centers such as Istanbul, Ankara, and Izmir. Consequently, this has led to the proliferation of private hospitals and healthcare establishments, thereby affording patients a greater array of options.
Private medical institutions in Turkey furnish an extensive spectrum of services, encompassing specialized treatments and catering to the demands of medical tourists. These hospitals are outfitted with cutting-edge technologies and state-of-the-art facilities, rendering them appealing to individuals in pursuit of top-notch healthcare services. Renowned for their elevated healthcare standards and personalized attention, private hospitals in Turkey have notably contributed to the flourishing of medical tourism in the nation. In addition, private sector investments have fostered the establishment of partnerships between the public and private sectors (PPP) in the realm of healthcare.
On the whole, the infusion of investments from the private sector has markedly propelled the expansion of Turkey's hospital market. This influence is evidenced by the augmented availability of high-caliber healthcare services, which, in turn, has presented patients with an expanded array of choices. These investments have also catalyzed the creation of groundbreaking healthcare services and heightened competition, thereby culminating in an elevation in the overall quality of healthcare services throughout the country.
Increasing Healthcare Needs Turkey Fuel the Growth of The Market
The expansion of the hospital market in Turkey has been significantly propelled by the mounting requirements for healthcare services. As the Turkish populace undergoes the process of aging, the prevalence of chronic ailments surges, consequently fostering a heightened demand for healthcare services. This phenomenon is steering the ongoing augmentation of the hospital sector within Turkey.
According to data from the Turkish Statistical Institute, the segment of the Turkish population aged 65 and above is projected to reach 10.2% in 2023 and escalate to 14.2% by 2050. This aging demographic is anticipated to necessitate an elevated quantity of healthcare services, encompassing hospitalization, specialized treatments, and long-term care.
Moreover, the incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is on the upswing in Turkey. These conditions mandate persistent medical attention and frequently culminate in hospital stays, thereby accentuating the demand for healthcare services. Furthermore, the COVID-19 pandemic has underscored the significance of a resilient healthcare system in Turkey. The exigencies of the pandemic have induced an augmented requirement for hospitalization, intensive care unit beds, and medical equipment, thus imposing stress on the healthcare infrastructure. Consequently, the Turkish government has escalated its investments in healthcare infrastructure and is actively engaged in fortifying the healthcare system.
On the whole, the escalating healthcare requisites within Turkey are projected to persist as a driving force behind the hospital market's expansion in the forthcoming years. This trajectory is set to stimulate the establishment of additional hospitals and healthcare facilities, ultimately culminating in an enhancement of the caliber and accessibility of healthcare services.
Medical Tourism Drive the Growth of The Turkey Hospital Market
The hospital market's expansion in Turkey has been notably energized by the phenomenon of medical tourism. The nation has emerged as a sought-after medical tourism destination, owing to its top-tier healthcare services, budget-friendly pricing, and alluring geographical location. Medical tourism encompasses the journey of individuals to foreign countries for medical treatment or surgical procedures. Turkey has garnered the attention of medical tourists originating from regions like the Middle East, Europe, and Central Asia. These individuals are enticed by a spectrum of treatments offered in Turkey, spanning cosmetic surgery, hair transplants, dental interventions, and fertility therapies. The nation is acclaimed for hosting specialized hospitals, with a particular focus on domains such as plastic surgery, dentistry, and ophthalmology.
The Turkish government has actively championed medical tourism, introducing several strategies to attract a greater influx of medical tourists to its shores. These strategies encompass the establishment of dedicated hospitals, the introduction of e-visas tailored for medical tourists, and the creation of medical tourism coordination offices.
he impetus generated by medical tourism has led to the augmentation of Turkey's hospital market by elevating the demand for healthcare services and fostering the establishment of specialized healthcare institutions. Simultaneously, it has furnished opportunities for investments from the private sector within the healthcare domain and has made a notable contribution to the nation's economic expansion.
Market Segmentation
Turkey Hospital Market is segmented based on type, type of services, and bed capacity. Based on type, the market is divided into general, multispecialty, and specialty. Based on type of service, the market is segmented into in-patient services and out-patient services. Based on bed capacity, the market is divided into above 500 beds, 100-500 beds, upto 100 beds.
Market players
liV Hospital, Anadolu Hastaneler Grubu, NPİSTANBUL Brain Hospital, Medical Park Hospital Group, Medipol Hospital, Memorial Hospital, Medicana Hospital, NP Istanbul Brain Hospital, Medical Park, Dunyagoz Hospital Group
Report Scope:
In this report, the Turkey Hospital Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Turkey Hospital Market, By Type:
- General
- Multispecialty
- Specialty
- Turkey Hospital Market, By Type of Service:
- In-Patient Services
- Out-Patient Services
- Turkey Hospital Market, By Bed Capacity
- Above 500 beds
- 100-500 beds
- up-to 100 beds
- Turkey Hospital Market, By Region
- Marmara Region
- Central Anatolia
- Eastern Anatolia Region
- South-Eastern Anatolia Region
- Aegean Region
- Mediterranean Region
- Black Sea Region
Company Profiles: Detailed analysis of the major companies present in the Turkey Hospital Market.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
- 2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
- 3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
- 4. Voice of Customer
- 5. Global Protein Characterization and Identification Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Product & Services (Consumables, Instruments, Services)
- 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
- 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
- 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
- 5.2.5. By Company (2022)
- 5.3. Market Map
- 5.3.1 By Product & Services
- 5.3.2 By Application
- 5.3.3 By End Use
- 5.3.4 By Region
- 6. North America Protein Characterization and Identification Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Product & Services (Consumables, Instruments, Services)
- 6.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
- 6.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Protein Characterization and Identification Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Product & Services
- 6.3.1.2.2. By Application
- 6.3.1.2.3. By End Use
- 6.3.2. Canada Protein Characterization and Identification Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Product & Services
- 6.3.2.2.2. By Application
- 6.3.2.2.3. By End Use
- 6.3.3. Mexico Protein Characterization and Identification Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Product & Services
- 6.3.3.2.2. By Application
- 6.3.3.2.3. By End Use
- 7. Europe Protein Characterization and Identification Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Product & Services (Consumables, Instruments, Services)
- 7.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
- 7.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Protein Characterization and Identification Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product & Services
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By End Use
- 7.3.2. Germany Protein Characterization and Identification Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product & Services
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By End Use
- 7.3.3. United Kingdom Protein Characterization and Identification Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product & Services
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By End Use
- 7.3.4. Italy Protein Characterization and Identification Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product & Services
- 7.3.4.2.2. By Application
- 7.3.4.2.3. By End Use
- 7.3.5. Spain Protein Characterization and Identification Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product & Services
- 7.3.5.2.2. By Application
- 7.3.5.2.3. By End Use
- 8. Asia-Pacific Protein Characterization and Identification Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Product & Services (Consumables, Instruments, Services)
- 8.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
- 8.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Protein Characterization and Identification Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product & Services
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By End Use
- 8.3.2. India Protein Characterization and Identification Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product & Services
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By End Use
- 8.3.3. Japan Protein Characterization and Identification Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product & Services
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By End Use
- 8.3.4. South Korea Protein Characterization and Identification Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product & Services
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By End Use
- 8.3.5. Australia Protein Characterization and Identification Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product & Services
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By End Use
- 9. South America Protein Characterization and Identification Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Product & Services (Consumables, Instruments, Services)
- 9.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
- 9.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Protein Characterization and Identification Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product & Services
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By End Use
- 9.3.2. Argentina Protein Characterization and Identification Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product & Services
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By End Use
- 9.3.3. Colombia Protein Characterization and Identification Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product & Services
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By End Use
- 10. Middle East and Africa Protein Characterization and Identification Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Product & Services (Consumables, Instruments, Services)
- 10.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
- 10.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Protein Characterization and Identification Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product & Services
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By End Use
- 10.3.2. Saudi Arabia Protein Characterization and Identification Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product & Services
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By End Use
- 10.3.3. UAE Protein Characterization and Identification Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product & Services
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By End Use
- 11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
- 12. Market Trends & Developments
- 12.1. Recent Development
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
- 13. Global Protein Characterization and Identification Market: SWOT Analysis
- 14. Porter’s Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
- 15. Competitive Landscape
- 15.1. Business Overview
- 15.2. Product Offerings
- 15.3. Recent Developments
- 15.4. Financials (As Reported)
- 15.5. Key Personnel
- 15.6. SWOT Analysis
- 15.6.1 Agilent Technologies
- 15.6.2 Analytik Jena
- 15.6.3 Bio-Rad Laboratories
- 15.6.4 Bruker Corporation
- 15.6.5 Cleaver Scientific
- 15.6.6 Danaher Corporation
- 15.6.7 Eurofins Scientific
- 15.6.8 Horiba
- 15.6.9 Jeol
- 15.6.10 Merck KGaA
- 15.6.11 PerkinElmer Inc
- 15.6.12 Promega Corporation
- 15.6.13 Qiagen NV
- 16. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook